Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/30519
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorJiménez, Fátima-
dc.contributor.authorGEA VELAZQUEZ DE CASTRO, MARÍA TERESA-
dc.contributor.authorPastor-Valero, Maria-
dc.contributor.authorAibar Remón, Carlos-
dc.contributor.authorMiralles-Bueno, Juan Jose-
dc.contributor.authorMeyer García, María del Carmen-
dc.contributor.authorAranaz Andrés, Jesús María-
dc.contributor.otherDepartamentos de la UMH::Salud Pública, Historia de la Ciencia y Ginecologíaes_ES
dc.date.accessioned2024-01-15T07:48:22Z-
dc.date.available2024-01-15T07:48:22Z-
dc.date.created2020-10-
dc.identifier.citationBMJ Open Volume 10, Issue 10es_ES
dc.identifier.issn2044-6055-
dc.identifier.urihttps://hdl.handle.net/11000/30519-
dc.description.abstractObjective To determine whether isolated patients admitted to hospital have a higher incidence of adverse events (AEs), to identify their nature, impact and preventability. Design Prospective cohort study with isolated and non-isolated patients. Setting One public university hospital in the Valencian Community (southeast Spain). Participants We consecutively collected 400 patients, 200 isolated and 200 non-isolated, age ≥18 years old, to match according to date of entry, admission department, sex, age (±5 years) and disease severity from April 2017 to October 2018. Exclusion criteria: patients age <18 years old and/or reverse isolation patients. Primary and secondary outcome measures The primary outcome as the AE, defined according to the National Study of Adverse Effects linked to Hospitalisation (Estudio Nacional Sobre los Efectos Adversos) criteria. Cumulative incidence rates and AE incidence density rates were calculated. Results The incidence of isolated patients with AEs 16.5% (95% CI 11.4% to 21.6%) compared with 9.5% (95% CI 5.4% to 13.6%) in non-isolated (p<0.03). The incidence density of patients with AEs among isolated patients was 11.8 per 1000 days/patient (95% CI 7.8 to 15.9) compared with 4.3 per 1000 days/patient (95% CI 2.4 to 6.3) among non-isolated patients (p<0.001). The incidence of AEs among isolated patients was 18.5% compared with 11% for non-isolated patients (p<0.09). Among the 37 AEs detected in 33 isolated patients, and the 22 AEs detected in 19 non-isolated patients, most corresponded to healthcare-associated infections (HAIs) for both isolated and non-isolated patients (48.6% vs 45.4%). There were significant differences with respect to the preventability of AEs, (67.6% among isolated patients compared with 52.6% among non-isolated patients). Conclusions AEs were significantly higher in isolated patients compared with non-isolated patients, more than half being preventable and with HAIs as the primary cause. It is essential to improve training and the safety culture of healthcare professionals relating to the care provided to this type of patient.es_ES
dc.formatapplication/pdfes_ES
dc.format.extent8es_ES
dc.language.isoenges_ES
dc.publisherBMJ Publishing Groupes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectisolated patientses_ES
dc.subjectnon-isolated patientses_ES
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicinaes_ES
dc.titleHigher incidence of adverse events in isolated patients compared with non-isolated patients: a cohort studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttp://dx.doi.org/10.1136/bmjopen-2019-035238-
Aparece en las colecciones:
Artículos Salud Pública, Historia de la Ciencia y Ginecología


Vista previa

Ver/Abrir:
 9-e035238.full.pdf

278,96 kB
Adobe PDF
Compartir:


Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.